ALL MASTERS UNDER ONE ROOF!

 

 

George Samandouras trained in Neurosurgery in Oxford receiving numerous teaching awards from the University of Oxford before becoming Consultant Neurosurgeon in November 2009 at the National Hospital for Neurology and Neurosurgery, the world's first institution specializing in brain pathologies. He runs a neuro-oncology service with high volume awake craniotomies and resection of gliomas in eloquent parts of the brain. He is invited annually to present his work to the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS) and other international societies. He is an invited member of the Executive Committee of the AANS/CNS joint section on tumours (2016-2020). His bestselling book "The Neurosurgeon's Handbook", Oxford University Press, has been translated to Chinese in 2015.

CONSULTANT NEUROSURGEON

THE NATIONAL HOSPITAL FOR

NEUROLOGY AND NEUROSURGERY

UNIVERSITY COLLEGE LONDON

QUEEN SQUARE, LONDON

Professor Berger is the Director of the Brain Tumor Surgery Program and Director of the Neurosurgical Research Centers. His main clinical interests are the treatment of brain tumours in adults and children. He has extensive expertise in the intraoperative mapping of the brain to identify the sites of the motor, sensory, and language function and thereby avoid their involvement or injury during surgery. His current research interests involve identifying molecular markers in gliomas as correlates of tumour progression and prognosis. Dr Berger is currently the Principal Investigator of UCSF's SPORE Brain Tumor Program, funded by the National Cancer Institute and NINDS. His articles, books and lectures have changed the practice of neurooncology worldwide.

 

PROFESSOR AND CHAIRMAN

DEPARTMENT OF NEUROSURGERY

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, USA

Professor Steven Kalkanis is the current President of the Congress of Neurological Surgeons (CNS). He is also co-Director of the Neuroscience Institute at Henry Ford Health System in Detroit, Michigan, where he also serves as Director of the Henry Ford Cancer Institute. Dr Kalkanis completed his neurosurgical training at Massachusetts General Hospital. He graduated with highest honours from Harvard University, where he was awarded the John Harvard Scholarship, and then Harvard Medical School, where he served as class marshal and received the Linnane Prize for highest academic achievement. He is involved in numerous trials, task forces and guidelines committees for the evidence-based management of brain tumours. He has a special interest in precision medicine.  

 

PROFESSOR AND CHAIRMAN, DEPARTMENT OF NEUROSURGERY, HENRY FORD HEALTH SYSTEM

DETROIT, MICHIGAN, USA

 

PRESIDENT,

CONGRESS OF NEUROLOGICAL SURGEONS

Dr Lawton’s neurosurgical expertise includes cerebrovascular disorders (aneurysms, arteriovenous malformations, cavernous malformations, and stroke) and skull base tumours. He has experience in treating more than 4,000 brain aneurysms, 800 AVMs, and 1,000 cavernous malformations. He is the principal investigator for the Brain Vascular Malformation Consortium, an NIH-funded multicenter group studying the genetics and clinical course of rare vascular diseases of the brain. He has published over 450 peer-reviewed articles, three single-author textbooks, and over 70 book chapters. He co-founded Mission: BRAIN, a teaching mission to raise the level of neurosurgery practised in developing countries that conducts annual missions in Mexico and Asia.

CHAIRMAN, DEPARTMENT OF NEUROLOGICAL SURGERY, BARROW BRAIN AND SPINE, PHOENIX, USA

 

PRESIDENT & CEO,

BARROW NEUROLOGICAL INSTITUTE

Dr Schwartz is among the nation’s leading neurological surgeons specializing in brain tumour and epilepsy surgery. He has been named to the lists of New York’s Super Doctors, Best Doctors in New York magazine, America’s Top Surgeons, America’s Best Doctors, and America’s Best Doctors for Cancer. His research has been widely published and he has received numerous national awards. He is particularly known for advancing the use of state-of-the-art intraoperative technology, such as minimally invasive endoscopy, brain mapping, and intraoperative imaging.

 

DAVID AND URSEL BARNES PROFESSOR OF MINIMALLY INVASIVE NEUROSURGERY 

DEPARTMENT OF NEUROSURGERY, OTOLARYNGOLOGY AND NEUROSCIENCE

 

DIRECTOR, ANTERIOR SKULL BASE AND PITUITARY SURGERY, DIRECTOR, EPILEPSY RESEARCH LABORATORY, WILL CORNELL MEDICINE,  USA

Professor Froelich has a wide range of expertise in skull base surgery and particularly chordomas, employing both open and endoscopic approaches. He runs very successful skull base courses worldwide, including developing countries. He has published numerous articles and monographs in skull base surgery.

 

 

 

 

 

 

 

PROFESSOR AND CHAIRMAN

DEPARTMENT OF NEUROSURGERY

LARIBOISIERE UNIVERSITY HOSPITAL

PARIS, FRANCE

Professor Lorenzo Bello leads a group of neurosurgeons, neurophysiologists, neuropsychologists dedicated in the treatment of brain tumours. An average of 500 cases of brain tumours are surgically treated each year (250 low grade), and an overall number of more than 2000 cases are treated by the group each year. His research is on brain mapping techniques, image-guided surgery, and translational research on angiogenesis and invasion. He is leading one the more active group in Europe on low-grade gliomas research. Most recent work is focused on the functional organization of the corticospinal tract, and on the connection between frontal and parietal areas. He is Co-director of the ELAT, an INSERM associated laboratory, studying mechanisms of angiogenesis and invasion in cancer.

 

PROFESSOR OF NEUROSURGERY

HEAD OF NEUROSURGICAL ONCOLOGY UNIT, 

HUMANITAS NEURO AND CANCER, CENTER, HUMANITAS RESEARCH HOSPITAL, MILANO, ITALY

Professor Duffau is Chairman of the Neurosurgery Department of the Montpellier University Medical Center and Head of the INSERM 1051 Team "Plasticity of the central nervous system, human stem cells and glial tumours" at the Institute for Neurosciences of Montpellier. He is an expert in the awake cognitive neurosurgery of slow-growing brain tumours, (low-grade gliomas), a routine which he has developed over twenty years. For his innovative work in neurosurgery and neurosciences, he was awarded Doctor Honoris Causa several times, and he was the youngest recipient of the prestigious Herbert Olivecrona Award from the Karolinska Institute in Stockholm. He has written four textbooks and over 300 publications in international journals ranging from neurosurgery to fundamental neurosciences.

 

PROFESSOR AND CHAIRMAN,

DEPARTMENT OF NEUROSURGERY

UNIVERSITY OF MONTPELLIER, FRANCE

Professor Ribas runs a research laboratory at the Hospital Beneficência Portuguesa, focusing on microneurosurgical anatomy and on cranial neurosurgical techniques; he has published more than 50 articles and 40 book chapters. He is a pioneer of stereoscopic publications in neurosurgical journals (Journal of Neurosurgery, December 2001, with its cover illustration), and his lectures are mostly done with 3D techniques since 1995. In 2010 his article The Cerebral Sulci and Gyri was the most accessed article of the whole Journal of Neurosurgery Publishing Group. He is a member of the editorial staff of the Neurosurgical Focus,  Journal of Neurosurgery Video Supplement and reviewer for Neurosurgery,  and World Neurosurgery. 

 

PROFESSOR OF SURGERY & NEUROSURGEON

UNIVERSITY OF SAO PAULO MEDICAL SCHOOL

ALBERT EINSTEIN HOSPITAL

BRAZIL

Dr. Türe showed special interest in white matter dissection after getting familiar with this technique in 1991 in Zurich and he presented it to the neurosurgical community by teaching neurosurgeons from all over the world with workshops and visiting laboratories. With these courses more than thousands of neurosurgeons have been educated on white matter dissection worldwide. International fellows have since had the chance to join to learn and improve this technique in this laboratory. In 2010, Dr. Türe established the “Istanbul Microneurosurgery Course” with his mentor Professor Yaşargil. 

PROFESSOR AND CHAIRMAN

DEPARTMENT OF NEUROSURGERY

YEDITEPE UNIVERSITY SPECIALITY HOSPITAL

ISTANBUL, TURKEY 

PAST PRESIDENT, WFNS

Professor Raabe's main clinical focus is the surgical treatment of brain tumours and vascular malformations. His main scientific focus is the development of techniques for protection of brain structures and function during surgery using advanced neuromonitoring or innovative technologies. Professor Raabe introduced indocyanine green video angiography for vascular lesions into neurosurgery and developed the technique of continuous brain stimulation for surgery adjacent to motor structures. In 2019 he was awarded the European Lecture of the EANS. Prof. Raabe has published more than 300 original scientific papers, review articles and technical notes. He is author of several book chapters and the editor of the Craniotomy Atlas. He is currently the chair of the vascular section of the EANS and active in the EANS training course.

 

 

PROFESSOR AND CHAIRMAN

DEPARTMENT OF NEUROSURGERY

UNIVERSITY HOSPITAL BERN, SWITZERLAND

Dr Stupp has been the lead investigator for establishing the use of temozolomide chemotherapy in conjunction with radiotherapy in patients with newly diagnosed glioblastoma and determining the predictive value of MGMT gene promoter methylation. He co-chairs several randomized clinical trials, including EORTC 22033-26033, comparing primary chemotherapy versus radiotherapy in patients with low-grade glioma, and trials on novel agents or modalities in patients with recurrent glioma. Dr Stupp maintains close collaborations with the Laboratory of Tumor Biology and Genetics at CHUV, the Laboratory of Tumor Angiogenesis and Melanoma Research, and the Swiss Institute of Experimental Cancer Research (ISREC).

 

CHIEF OF NEURO-ONCOLOGY

FEINBERG SCHOOL OF MEDICINE

NORTHWESTERN MEDICINE

CHICAGO, IL, USA

Dr. Chang performs clinical trials about brain tumour therapy protocols and experimental therapeutic regimens for adult patients. In addition to research into developing novel and effective therapeutic strategies for the treatment of patients with primary brain tumours, her research goals include the evaluation of novel imaging techniques that may influence treatment selection for patients. She is the Neuro-Oncology Program Leader of the UCSF comprehensive cancer centre and is co-PI of a program project grant evaluating imaging and tissue biomarkers of glioblastoma. She has recently been co-recipient of a SPORE project for evaluating the role of magnetic resonance spectroscopy in diagnosing tumours and evaluating therapeutic interventions. She is also the chair of the Developmental Study Section at the NIH. 

 

DIRECTOR, NEURO-ONCOLOGY DIVISION & LEADER, NEURO-ONCOLOGY PROGRAM, HELEN DILLER COMPREHENSIVE CANCER CENTER, UNIVERISITY OF CALIFORNIA, SAN FRANCISCO, USA 

 

EDITOR-IN-CHIEF NEUROONCOLOGY PRACTICE

Spyros Sgouros is the current President of the European Society for Pediatric Neurosurgery and Past President of the International Federation for Neuroendoscopy. He specializes in Pediatric Neurosurgery, with main focus on pediatric brain tumours, neuroendoscopy, hydrocephalus, syringomyelia, congenital malformations and craniofacial disorders. He has published over 140 peer-reviewed papers in these fields. He graduated from the “National and Kapodistrian” University of Athens, Greece and trained in neurosurgery mostly in the United Kingdom, but also in France (Necker Enfants Malades Hospital) and Germany (Krankenhous Nordstat Hannover). He served as Consultant Neurosurgeon at the Birmingham Childrens Hospital and as Senior Lecturer in Neurosurgery at University of Birmingham, UK for ten years. Twelve years ago he returned to his native country Greece, where he is Professor of Neurosurgery at the “National and Kapodistrian” University of Athens and Head of Pediatric Neurosurgery at “Mitera” Children’s Hospital.

 

PROFESSOR AND HEAD OF PAEDIATRIC NEUROSURGERY, MITERA CHILDRENS HOSPITAL

ATHENS, GREECE 

 

PRESIDENT, EUROPEAN SOCIETY

OF PAEDIATRIC NEUROSURGERY

Dr Brennan specialises in the neurosurgical management of adult brain tumours. He splits his clinic time with laboratory and clinical research. His research leverages his clinical experience, combining deeply annotated patient and ‘omics' data to enhance our understanding about brain tumour development and therapy responsiveness. In the laboratory he probes mechanistic hypotheses generated by these analyses, using large scale clinical data to drive discovery science.  He collaborates on bringing innovative technologies to the clinic, developing the clinical and scientific evidence for adoption in routine care, such as the Clinspec Dx spectroscopic liquid biopsy test that can both stratify tumour risk in a symptomatic patient population, and predict tumour phenotype. 

SENIOR CLINICAL LECTURER AND HONORARY CONSULTANT NEUROSURGEON

UNIVERSITY OF EDINBURGH